Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Sleep Medication Market Heading Into 2029?

In recent years, the sleep medication market has experienced significant expansion. The market size, which was $23.94 billion in 2024, will elevate to $25.92 billion in 2025, following a compound annual growth rate (CAGR) of 8.3%. The historic growth in the market can be credited to factors like the escalating usage of prescribed sleep aids, an increase in chronic illnesses that negatively impact sleep, a surge in mental health problems, a growing demand for over-the-counter sleep remedies, and the uptake of digital health and telemedicine.

The market for sleep aids is predicted to experience robust expansion in the forthcoming years, increasing to $35.3 billion in 2029 with an 8.0% compound annual growth rate (CAGR). This projected growth during the forecast period can be attributed to factors such as the growing adoption of tailor-made medicine, escalating investments in sleep disorder studies, heightened awareness via digital health networks, surging demand for organic and herbal sleep aids, and the increasing occurrence of sleep apnea and corresponding disorders. Significant trends within the forecast period include the progress in drug delivery technologies, enhancements in the creation of extended-release sleep aids, the advent of wearable sleep tracking devices, advancements in cognitive behavioral therapy-oriented digital tools, and the establishment of combined treatments for sleep disorders.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24702&type=smp

Which Factors Are Pushing The Sleep Medication Market Forward?

The growth of the sleep medication market is anticipated to accelerate due to the rising incidence of mental health disorders. Mental illness spans a broad spectrum of conditions that impact an individual’s mood, thought process, behavior, and general performance. The climbing rate of mental illness can be attributed to the increasing levels of chronic stress, as long-standing stress hampers brain activity and initiates or exacerbates mental health issues. Sleep medication plays a crucial role in managing mental illnesses by improving the quality of sleep, which is usually disturbed in individuals with mental health problems. These medications aid in regulating the sleep-wake cycle, alleviating symptoms like insomnia and anxiety, thereby improving overall mental health and everyday performance. For instance, as per the National Institute of Mental Health, a research agency funded by the US government, 59.3 million adults aged 18 and above in the United States suffered from mental illness (AMI) in 2022, making up 23.1% of the entire adult population. Consequently, the escalating incidence of mental illness is fueling the expansion of the sleep medication market.

Which Segment Held The Largest Share In The Sleep Medication Market In 2025?

The sleep medication market covered in this report is segmented –

1) By Type: Prescription-Based Drugs, Over-The-Counter (OTC) Drugs

2) By Sleep Disorder Type: Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking, Other Sleep Disorders

3) By Drug Class, Benzodiazepines: Antidepressants, Antihistamines, Sedating Antipsychotics, Other Drug Classes

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-Users: Hospitals, Homecare, Speciality Centres, Other End-Users

Subsegments:

1) By Prescription-Based Drugs: Benzodiazepines, Non-Benzodiazepine Hypnotics, Melatonin Receptor Agonists, Orexin Receptor Antagonists, Antidepressants, Antipsychotics, Antihistamines

2) By Over-The-Counter (OTC) Drugs: Antihistamines, Melatonin Supplements, Herbal Supplements, Dietary Supplements, Homeopathic Remedies

How Are Key Trends Driving Expansion In The Sleep Medication Industry?

Leading firms in the sleep medication market are prioritizing the creation of innovative products, like dual orexin receptor antagonists (DORAs), in an attempt to deliver more specific treatments for insomnia that carry less risk of side effects and dependency. Dual orexin receptor antagonists (DORAs) are a type of sleep medicine that assists the management of the sleep-wake cycle by treating insomnia via the blockade of orexin neuropeptides chemicals which stimulate wakefulness via the inhibition of both orexin receptors (OX1R and OX2R). An example is Idorsia Pharmaceuticals Ltd., a Swiss pharmaceutical enterprise, which in January 2022, received endorsement from the U.S. Food and Drug Administration (FDA) for QUVIVIQ (daridorexant) 25 mg and 50 mg for the remediation of insomnia in adult patients. This is a dual orexin receptor antagonist (DORA) that operates by blocking the attachment of orexins, neuropeptides that promote wakefulness, thereby facilitating regulation of the sleep-wake cycle without the necessity of sedating the brain.

Which Organizations Are Driving Progress In The Sleep Medication Industry?

Major companies operating in the sleep medication market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Perrigo Company plc, H. Lundbeck A/S, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Vanda Pharmaceuticals Inc., Natrol LLC

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/sleep-medication-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Sleep Medication Industry?

North America was the largest region in the sleep medication market in 2024. The regions covered in the sleep medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24702&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model